- Home
- MOVE vs APRE Comparison
MOVE vs APRE Comparison
Compare MOVE & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOVE | APRE |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.4M | 8.4M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MOVE | APRE |
|---|---|---|
| Price | $17.25 | $0.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.10 |
| AVG Volume (30 Days) | 103.1K | ★ 437.4K |
| Earning Date | 04-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.22 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $433,000.00 | N/A |
| Revenue This Year | $1,460.71 | N/A |
| Revenue Next Year | $96.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $0.55 |
| 52 Week High | $34.87 | $2.22 |
Technical Indicators
Market Signals| Indicator | MOVE | APRE |
|---|---|---|
| Relative Strength Index (RSI) | 61.83 | 59.27 |
| Support Level | $6.27 | $0.90 |
| Resistance Level | $20.62 | $0.98 |
| Average True Range (ATR) | 1.93 | 0.10 |
| MACD | 0.51 | 0.02 |
| Stochastic Oscillator | 100.00 | 62.71 |
Price Performance
Historical ComparisonAbout MOVE Movano Inc.
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.
About APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.